Cargando…
The Effectiveness of Paracetamol to Reduce the Post-Vaccination SARS-CoV-2 Adverse Effects in an Italian Vaccination Center
The arrival of specific vaccines was crucial for the eradication of COVID-19. Despite the security of the vaccination, the administration of COVID-19 mRNA vaccines often causes systemic side effects for a short time after the injection, such as headache, fatigue, fever, muscle pain and nausea. These...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534772/ https://www.ncbi.nlm.nih.gov/pubmed/37766169 http://dx.doi.org/10.3390/vaccines11091493 |
_version_ | 1785112472993136640 |
---|---|
author | Ricci, Eleonora Glavasc, Anamaria Morandini, Barbara Grassi, Maria Caterina La Torre, Giuseppe |
author_facet | Ricci, Eleonora Glavasc, Anamaria Morandini, Barbara Grassi, Maria Caterina La Torre, Giuseppe |
author_sort | Ricci, Eleonora |
collection | PubMed |
description | The arrival of specific vaccines was crucial for the eradication of COVID-19. Despite the security of the vaccination, the administration of COVID-19 mRNA vaccines often causes systemic side effects for a short time after the injection, such as headache, fatigue, fever, muscle pain and nausea. These side effects can limit the adherence to COVID-19 vaccines administration, especially in healthcare workers. This study aims to analyze the impact of the prophylactic use of paracetamol to reduce the post-vaccination Comirnaty/Pfizer adverse effects. The study took place at the San Giovanni Battista Hospital in Rome and included all hospital employees who received two doses of Pfizer-BioNTech. The vaccination health personnel recommended the preventive intake of 1 g of paracetamol before the inoculation of the vaccine and then every 6 h in the first 24 h. Information was collected through forms and subsequent telephone recall. A total of 403 volunteers were involved in the study, with 391 of them receiving two doses and twelve individuals only one dose of the vaccine. The main results demonstrated that the prophylactic therapy influenced the lower onset of asthenia in the first and second doses. However, there were no significant differences between the two groups in terms of fever, headache and localized pain. Paracetamol had a good impact on the side effect of COVID-19 vaccination, reducing asthenia in both doses and mitigating the total of symptoms during the second vaccination. |
format | Online Article Text |
id | pubmed-10534772 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105347722023-09-29 The Effectiveness of Paracetamol to Reduce the Post-Vaccination SARS-CoV-2 Adverse Effects in an Italian Vaccination Center Ricci, Eleonora Glavasc, Anamaria Morandini, Barbara Grassi, Maria Caterina La Torre, Giuseppe Vaccines (Basel) Article The arrival of specific vaccines was crucial for the eradication of COVID-19. Despite the security of the vaccination, the administration of COVID-19 mRNA vaccines often causes systemic side effects for a short time after the injection, such as headache, fatigue, fever, muscle pain and nausea. These side effects can limit the adherence to COVID-19 vaccines administration, especially in healthcare workers. This study aims to analyze the impact of the prophylactic use of paracetamol to reduce the post-vaccination Comirnaty/Pfizer adverse effects. The study took place at the San Giovanni Battista Hospital in Rome and included all hospital employees who received two doses of Pfizer-BioNTech. The vaccination health personnel recommended the preventive intake of 1 g of paracetamol before the inoculation of the vaccine and then every 6 h in the first 24 h. Information was collected through forms and subsequent telephone recall. A total of 403 volunteers were involved in the study, with 391 of them receiving two doses and twelve individuals only one dose of the vaccine. The main results demonstrated that the prophylactic therapy influenced the lower onset of asthenia in the first and second doses. However, there were no significant differences between the two groups in terms of fever, headache and localized pain. Paracetamol had a good impact on the side effect of COVID-19 vaccination, reducing asthenia in both doses and mitigating the total of symptoms during the second vaccination. MDPI 2023-09-15 /pmc/articles/PMC10534772/ /pubmed/37766169 http://dx.doi.org/10.3390/vaccines11091493 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ricci, Eleonora Glavasc, Anamaria Morandini, Barbara Grassi, Maria Caterina La Torre, Giuseppe The Effectiveness of Paracetamol to Reduce the Post-Vaccination SARS-CoV-2 Adverse Effects in an Italian Vaccination Center |
title | The Effectiveness of Paracetamol to Reduce the Post-Vaccination SARS-CoV-2 Adverse Effects in an Italian Vaccination Center |
title_full | The Effectiveness of Paracetamol to Reduce the Post-Vaccination SARS-CoV-2 Adverse Effects in an Italian Vaccination Center |
title_fullStr | The Effectiveness of Paracetamol to Reduce the Post-Vaccination SARS-CoV-2 Adverse Effects in an Italian Vaccination Center |
title_full_unstemmed | The Effectiveness of Paracetamol to Reduce the Post-Vaccination SARS-CoV-2 Adverse Effects in an Italian Vaccination Center |
title_short | The Effectiveness of Paracetamol to Reduce the Post-Vaccination SARS-CoV-2 Adverse Effects in an Italian Vaccination Center |
title_sort | effectiveness of paracetamol to reduce the post-vaccination sars-cov-2 adverse effects in an italian vaccination center |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534772/ https://www.ncbi.nlm.nih.gov/pubmed/37766169 http://dx.doi.org/10.3390/vaccines11091493 |
work_keys_str_mv | AT riccieleonora theeffectivenessofparacetamoltoreducethepostvaccinationsarscov2adverseeffectsinanitalianvaccinationcenter AT glavascanamaria theeffectivenessofparacetamoltoreducethepostvaccinationsarscov2adverseeffectsinanitalianvaccinationcenter AT morandinibarbara theeffectivenessofparacetamoltoreducethepostvaccinationsarscov2adverseeffectsinanitalianvaccinationcenter AT grassimariacaterina theeffectivenessofparacetamoltoreducethepostvaccinationsarscov2adverseeffectsinanitalianvaccinationcenter AT latorregiuseppe theeffectivenessofparacetamoltoreducethepostvaccinationsarscov2adverseeffectsinanitalianvaccinationcenter AT riccieleonora effectivenessofparacetamoltoreducethepostvaccinationsarscov2adverseeffectsinanitalianvaccinationcenter AT glavascanamaria effectivenessofparacetamoltoreducethepostvaccinationsarscov2adverseeffectsinanitalianvaccinationcenter AT morandinibarbara effectivenessofparacetamoltoreducethepostvaccinationsarscov2adverseeffectsinanitalianvaccinationcenter AT grassimariacaterina effectivenessofparacetamoltoreducethepostvaccinationsarscov2adverseeffectsinanitalianvaccinationcenter AT latorregiuseppe effectivenessofparacetamoltoreducethepostvaccinationsarscov2adverseeffectsinanitalianvaccinationcenter |